Advertisement |  | | | | | TABLE OF CONTENTS
| | | | | Volume 118, Issue 3 (309-458)
Published online 7 February 2018
|  | In this issue
 Editorial
Review
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology
Letters to the Editor
Also new today
 Advance online publication
Digital Edition
| | | | Editorial | Top | | Back from the dead: TIL apoptosis in cancer immune evasion Brendan L Horton and Thomas F Gajewski Br J Cancer 2018 118: 309-311; advance online publication, January 23, 2018; 10.1038/bjc.2017.483 Full Text | | Review | Top | | Combining DNA damaging therapeutics with immunotherapy: more haste, less speed Jessica S Brown, Raghav Sundar and Juanita Lopez Br J Cancer 2018 118: 312-324; advance online publication, November 9, 2017; 10.1038/bjc.2017.376 Abstract | Full Text | | Clinical Studies | Top | | Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study Maëva Salimon, Caroline Prieux-Klotz, David Tougeron, Vincent Hautefeuille, Morgane Caulet, Jérôme Gournay, Tamara Matysiak-Budnik, Jaafar Bennouna, Manuela Tiako Meyo, Thierry Lecomte, Aziz Zaanan and Yann Touchefeu Br J Cancer 2018 118: 325-330; advance online publication, November 23, 2017; 10.1038/bjc.2017.413 Abstract | Full Text | | | | Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial Yusuke Shimodaira, Rebecca S Slack, Kazuto Harada, Hsiang-Chun Chen, Tara Sagebiel, Manoop S Bhutani, Jeffrey H Lee, Brian Weston, Elena Elimova, Quan Lin, Fatemeh G Amlashi, Dilsa Mizrak Kaya, Mariela A Blum, Jack A Roth, Stephen G Swisher, Heath D Skinner, Wayne L Hofstetter, Jane E Rogers, Jaennette Mares, Irene Thomas, Dipen M Maru, Ritsuko Komaki, Garrett Walsh and Jaffer A Ajani Br J Cancer 2018 118: 331-337; advance online publication, December 12, 2017; 10.1038/bjc.2017.423 Abstract | Full Text | | | | S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study X Wang, D B Zhao, L Yang, Y Chi, Y Tang, N Li, S L Wang, Y W Song, Y P Liu, W Y Liu, H Ren, T Zhang, J Y Wang, X S Chen, H Fang, W H Wang, Y X Li and J Jin Br J Cancer 2018 118: 338-343; advance online publication, December 12, 2017; 10.1038/bjc.2017.424 Abstract | Full Text | | | | Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2 Rastislav Bahleda, Andrea Varga, Yann Bergé, Jean-Charles Soria, David Schnell, Inga Tschoepe, Martina Uttenreuther-Fischer and Jean-Pierre Delord Br J Cancer 2018 118: 344-352; advance online publication, January 16, 2018; 10.1038/bjc.2017.436 Abstract | Full Text | | Translational Therapeutics | Top | | Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiation Hao Feng, Jing-kun Zhao, Tobias S Schiergens, Pu-xiongzhi Wang, Bao-chi Ou, Rami Al-Sayegh, Ming-lun Li, Ai-guo Lu, Shuai Yin and Wolfgang E Thasler Br J Cancer 2018 118: 353-365; advance online publication, January 2, 2018; 10.1038/bjc.2017.415 Abstract | Full Text | | | | MTOR inhibitor-based combination therapies for pancreatic cancer Zonera Hassan, Christian Schneeweis, Matthias Wirth, Christian Veltkamp, Zahra Dantes, Benedikt Feuerecker, Güralp O Ceyhan, Shirley K Knauer, Wilko Weichert, Roland M Schmid, Roland Stauber, Alexander Arlt, Oliver H Krämer, Roland Rad, Maximilian Reichert, Dieter Saur and Günter Schneider Br J Cancer 2018 118: 366-377; advance online publication, January 2, 2018; 10.1038/bjc.2017.421 Abstract | Full Text | | | | HER2 expression patterns in paired primary and metastatic endometrial cancer lesions Mari Kyllesø Halle, Ingvild Løberg Tangen, Hege Fredriksen Berg, Erling Andre Hoivik, Karen K Mauland, Kanthida Kusonmano, Anna Berg, Antoni Hurtado, Karl Henning Kalland, Anne M Øyan, Ingunn Stefansson, Olav K Vintermyr, Henrica M Werner, Ingfrid S Haldorsen, Jone Trovik, Helga B Salvesen and Camilla Krakstad Br J Cancer 2018 118: 378-387; advance online publication, November 23, 2017; 10.1038/bjc.2017.422 Abstract | Full Text | | | | Flavopiridol enhances ABT-199 sensitivity in unfavourable-risk multiple myeloma cells in vitro and in vivo Liang Zhou, Yu Zhang, Deepak Sampath, Joel Leverson, Yun Dai, Maciej Kmieciak, Matthew Nguyen, Robert Z Orlowski and Steven Grant Br J Cancer 2018 118: 388-397; advance online publication, December 14, 2017; 10.1038/bjc.2017.432 Abstract | Full Text | | Molecular Diagnostics | Top | | Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients D Zugna, R Senetta, S Osella-Abate, M T Fierro, A Pisacane, A Zaccagna, A Sapino, V Bataille, A Maurichi, F Picciotto, P Cassoni, P Quaglino and S Ribero Br J Cancer 2018 118: 398-404; advance online publication, November 9, 2017; 10.1038/bjc.2017.397 Abstract | Full Text | | | | Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia Li Tan, Hongfa Xu, Guoshu Chen, Xiaoping Wei, Baodan Yu, Jingmei Ye, Lihua Xu and Huo Tan Br J Cancer 2018 118: 405-415; advance online publication, January 2, 2018; 10.1038/bjc.2017.403 Abstract | Full Text | | | | The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells Peng Li, Jinbo Chen, Eiji Kashiwagi, Taichi Mizushima, Bin Han, Satoshi Inoue, Hiroki Ide, Koji Izumi and Hiroshi Miyamoto Br J Cancer 2018 118: 416-420; advance online publication, November 14, 2017; 10.1038/bjc.2017.404 Abstract | Full Text | | | | Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis Valtteri Häyry, Åsa Kågedal, Eric Hjalmarsson, Pedro Farrajota Neves da Silva, Cecilia Drakskog, Gregori Margolin, Susanna Kumlien Georén, Eva Munck-Wikland, Ola Winqvist and Lars Olaf Cardell Br J Cancer 2018 118: 421-427; advance online publication, November 23, 2017; 10.1038/bjc.2017.408 Abstract | Full Text | | | | Treponema denticola chymotrypsin-like proteinase may contribute to orodigestive carcinogenesis through immunomodulation Mikko T Nieminen, Dyah Listyarifah, Jaana Hagström, Caj Haglund, Daniel Grenier, Dan Nordström, Veli-Jukka Uitto, Marcela Hernandez, Tülay Yucel-Lindberg, Taina Tervahartiala, Mari Ainola and Timo Sorsa Br J Cancer 2018 118: 428-434; advance online publication, November 16, 2017; 10.1038/bjc.2017.409 Abstract | Full Text | | Genetics & Genomics | Top | | A core matrisome gene signature predicts cancer outcome Arseniy E Yuzhalin, Tomas Urbonas, Michael A Silva, Ruth J Muschel and Alex N Gordon-Weeks Br J Cancer 2018 118: 435-440; advance online publication, January 23, 2018; 10.1038/bjc.2017.458 Abstract | Full Text | | Epidemiology | Top | | Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006–2014) Benjamin Daniels, Belinda E Kiely, Nehmat Houssami, Sarah J Lord, Timothy Dobbins, Christine Y Lu, Robyn L Ward and Sallie-Anne Pearson Br J Cancer 2018 118: 441-447; advance online publication, November 14, 2017; 10.1038/bjc.2017.405 Abstract | Full Text | | | | Alcohol and oestrogen metabolites in postmenopausal women in the Women’s Health Initiative Observational Study Mary C Playdon, Sally B Coburn, Steven C Moore, Louise A Brinton, Nicolas Wentzensen, Garnet Anderson, Robert Wallace, Roni T Falk, Ruth Pfeiffer, Xia Xu and Britton Trabert Br J Cancer 2018 118: 448-457; advance online publication, December 12, 2017; 10.1038/bjc.2017.419 Abstract | Full Text | | Letters to the Editor | Top | | Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’ Isabel Bravo Br J Cancer 2018 118: e1; advance online publication, November 16, 2017; 10.1038/bjc.2017.342 Full Text | | | | Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’ Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, Filippo Alongi and Michela Buglione Br J Cancer 2018 118: e2; advance online publication, November 16, 2017; 10.1038/bjc.2017.406 Full Text | | | | Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system’ Sandra Tapial, Daniel Rueda, María Arriba, Juan Luis García, Lorena Brandáriz, Jessica Pérez, Yolanda Rodríguez, Damián García-Olmo, Rogelio González-Sarmiento, Miguel Urioste and José Perea Br J Cancer 2018 118: e3; advance online publication, January 2, 2018; 10.1038/bjc.2017.343 Full Text | | | | Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system” Jeong Mo Bae, Jung Ho Kim, Yoonjin Kwak, Dae-Won Lee, Yongjun Cha, Xianyu Wen, Tae Hun Lee, Nam-Yun Cho, Seung-Yong Jeong, Kyu Joo Park, Sae Won Han, Hye Seung Lee, Tae-You Kim and Gyeong Hoon Kang Br J Cancer 2018 118: e4; advance online publication, January 2, 2018; 10.1038/bjc.2017.426 Full Text | | | | Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer’ Paolo Bossi, Roberta Granata, Ester Orlandi and Lisa Licitra Br J Cancer 2018 118: e5; advance online publication, January 23, 2018; 10.1038/bjc.2017.416 Full Text | | | | Reply to ‘Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer” Steffen Wagner, Claus Wittekindt, Shachi Jenny Sharma, Nora Wuerdemann, Theresa Jüttner, Miriam Reuschenbach, Elena-Sophie Prigge, Magnus von Knebel Doeberitz, Stefan Gattenlöhner, Ernst Burkhardt, Jörn Pons-Kühnemann and Jens Peter Klussmann Br J Cancer 2018 118: e6; advance online publication, January 23, 2018; 10.1038/bjc.2017.464 Full Text | | | | Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis’ Zu-Bing Mei, Chun-Sheng Luo, Qing-Ming Wang and Wei Yang Br J Cancer 2018 118: e7; advance online publication, January 4, 2018; 10.1038/bjc.2017.444 Full Text | | | | Reply to ‘Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis” Alex Gordon-Weeks Br J Cancer 2018 118: e8; advance online publication, January 4, 2018; 10.1038/bjc.2017.445 Full Text | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | | |
No comments:
Post a Comment